Latest / Chip Stock Investor Podcast
Episode 55: Is Intuitive Surgical Stock Sunk Because of Ozempic and GLP-1 Weight Loss Drugs?
Intuitive Surgical (ISRG) is one of our favorite “forever stocks” at Chip Stock Investor, best known for its Da Vinci robotic surgical system. The company's stock has been a strong performer over the long term, but it has recently come under pressure due to the growing popularity of GLP-1 (glucagon-like peptide-1) weight-loss drugs like Ozempic. GLP-1s are also associated with a number of other health benefits, including a reduced risk of diabetes and heart disease. It appears the popularity of Ozempic is already having an impact on Intuitive Surgical's business, and some investors worry…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.